DIVI'S LABORATORIES Q2 FY27 ; NET PROFIT UP 64% AT ₹1,127 CR (YOY), UP 25% (QOQ)

REVENUE UP 35% AT ₹3,676 CR (YOY), UP 19% (QOQ) EBITDA UP 76% AT ₹1,566 CR (YOY), UP 25% (QOQ) MARGINS AT 42.6% VS 32.7% (YOY), 40.7% (QOQ)

DIVI S LABORATORIES LTD